Vascular Endothelial Growth Factor Insertion/Deletion gene polymorphism in patients with type 2 diabetes and diabetic peripheral polyneuropathy

@article{Stoian2014VascularEG,
  title={Vascular Endothelial Growth Factor Insertion/Deletion gene polymorphism in patients with type 2 diabetes and diabetic peripheral polyneuropathy},
  author={Adina Stoian and Anca Bac{\^a}rea and Anca Moţăţăianu and Mircea Stoian and Florina Ioana Gliga and Vladimir Constantin Bac{\^a}rea and Carmen Duicu and Claudia Bănescu},
  journal={Romanian Review of Laboratory Medicine},
  year={2014},
  volume={22},
  pages={165 - 172}
}
Abstract The aim of this work was to study for the first time in Romania Insertion/Deletion (I/D) polymorphism of the Vascular Endothelial Growth Factor (VEGF) gene in a group of patients with established type 2 diabetes mellitus (DM) and diabetic peripheral neuropathy (DPN) compared with a control group. This was a case-control study consisting of a group of 84 patients with type 2 DM and DPN, diagnosed by clinical neurological examination and electrophysiological nerve conduction studies and… 

Figures and Tables from this paper

18bp Fragment Insertion/Deletion Polymorphism of Vascular Endothelial Growth Factor (VEGF) Gene with Diabetes Mellitus Type 2 and Diabetic Retinopathy Patients of Quetta, Balochistan, Pakistan
TLDR
The findings suggest that the DD genotype is possible risk factor for development and progression of retinopathy as compared to uncomplicated subject II genotype in local population.
VEGF Promoter Region 18-bp Insertion-Deletion Polymorphism in Sickle Cell Disease Patients with Microalbuminuria: A Pilot Study
TLDR
D allele in I/D polymorphism in the promoter region of VEGF gene may be associated with marginal increase in risk of susceptibility to sickle cell nephropathy.
Ethnic differences in the +405 and −460 vascular endothelial growth factor polymorphisms and peripheral neuropathy in patients with diabetes residing in a North London, community in the United Kingdom
TLDR
An association was found between VEGF +405 genotypes and Indo-Asian which might have relevance to their lower rates of ulceration and amputation, which highlights the need for further investigation of any possible relationship between VegF genotype, circulating V EGF concentrations and differential vulnerability to peripheral neuropathy amongst diabetic patients of different ethnic backgrounds.
Genetic Variants and Their Associations to Type 2 Diabetes Mellitus Complications in the United Arab Emirates
TLDR
Associations of different genetic polymorphisms with microvascular complications and their combinations in Emirati T2DM patients are reported, reporting new associations, and corroborating previous findings.
Influence of GSTM1, GSTT1, and GSTP1 Polymorphisms on Type 2 Diabetes Mellitus and Diabetic Sensorimotor Peripheral Neuropathy Risk
TLDR
The data suggest that GSTP1 gene polymorphisms may contribute to the development of T2DM in Romanian population and are not associated with susceptibility of developing diabetic neuropathy in T1DM patients.
Identifying Common Genetic Risk Factors of Diabetic Neuropathies
TLDR
This article is the first to provide a review of the genetic risk variants implicated in the diabetic neuropathies and to highlight potential commonalities to contribute to the creation of a genetic-metabolic model that will help to elucidate the cause of diabetic neuro Pathies, evaluate a patient’s risk profile, and ultimately facilitate preventative and targeted treatment for the individual.
Nerve conduction studies in patients with type 2 diabetes mellitus in Basrah
TLDR
Even in asymptomatic patients, nerve conduction studies show diffuse changes, in a predictable pattern, and electrophysiological finding correlate with age, duration of disease, glycosylated hemoglobin levels, fasting blood glucose, type of the treatment if only oral antidiabetic and body mass index.
Is there an Association Between-2549 Insertion/Deletion Polymorphisms in the Promotor Region of the Gene Encoding for VEGFA as a Risk Factor and the Idiopathic Recurrent Spontaneous Miscarriage in a Sample of Jordanian Women?
TLDR
Azzam OA1*, Mahgoub SS2,3, Farhan SS4, Alrawashdeh HM5, Abufraijeh SM6 and Abd El kareemHM7,8 are students of Mutah University, Jordan.
...
...

References

SHOWING 1-10 OF 28 REFERENCES
Association of the VEGF gene polymorphism with diabetic retinopathy in type 2 diabetes patients.
TLDR
The study suggests that the I/D polymorphism in the promoter region of the VEGF gene is associated with retinopathy but not nephropathy in type 2 diabetes patients.
VEGF gene polymorphism association with diabetic neuropathy
TLDR
The present study indicates that polymorphism of the VEGF gene at position −7*C/T might be implicated in the pathogenesis of diabetic neuropathy as it may harbour some functional/regulatory potential in V EGF gene expression.
The vascular endothelial growth factor-2549 insertion/deletion polymorphism is not associated with susceptibility to hepatocellular carcinoma in Chinese.
TLDR
Estimating the susceptibility to HCC associated with an 18-bp insertion/deletion polymorphism in the promoter region of VEGF found that rs35569394 was not associated with HCC, at both the allele and genotype levels.
Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter.
TLDR
Carriage of the -460/+405 polymorphism significantly alters VEGF promoter activity and responsiveness, which has implications for the inherited susceptibility of common diseases.
Adiponectin gene 45 T > G polymorphism is not associated to plasma adiponectin in a cohort of patients with type 2 diabetes from Romania Polimorfismul 45
TLDR
The ADIPOQ 45T> G polymorphism did not influence plasma adiponectin levels in a cohort of patients with type 2 diabetes from Romania.
The predictive value of serum intercellular adhesion molecule 1 for the progression of diabetic kidney disease in type 2 diabetic patients
TLDR
It seems that ICAM-1 might be useful non-invasive biomarker in predicting the progression of DKD, with a particular role in albuminuric patients.
Role of vascular endothelial growth factor in diabetic vascular complications.
TLDR
Improved understanding of the molecular mechanisms underlying these processes has permitted development of novel therapeutic interventions, several of which are now in human clinical trials, and various implications for the future care of vasculopathy associated with diabetes will be discussed.
The role of growth factors in diabetic peripheral neuropathy
TLDR
This review surveys the roles of several growth factors in diabetic neuropathy, including the neurotrophins, insulin‐like growth factors, cytokine‐likegrowth factors, and vascular endothelial growth factor, and their protective and regenerative effects on peripheral neurons.
Relationship between soluble intercellular adhesion molecule 1 and clinically manifest cardiovascular disease in diabetic chronic hemodialysis patients
TLDR
Clinically apparent CVD i n diabetic hemodialysis-treated patients was associated with high sICAM-1 levels and the ACEI treatment and be tter glycemic control were associated with lower levels of ICAM- 1.
...
...